The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
The Colorado Thyroid Disease Prevalence Study
Abstract
CONTEXT: The prevalence of abnormal thyroid function in the United States and the significance of thyroid dysfunction remain controversial. Systemic effects of abnormal thyroid function have not been fully delineated, particularly in cases of mild thyroid failure. Also, the relationship between traditional hypothyroid symptoms and biochemical thyroid function is unclear. OBJECTIVE: To determine the prevalence of abnormal thyroid function and the relationship between (1) abnormal thyroid function and lipid levels and (2) abnormal thyroid function and symptoms using modern and sensitive thyroid tests. DESIGN: Cross-sectional study. PARTICIPANTS: Participants in a statewide health fair in Colorado, 1995 (N = 25 862). MAIN OUTCOME MEASURES: Serum thyrotropin (thyroid-stimulating hormone [TSH]) and total thyroxine (T4) concentrations, serum lipid levels, and responses to a hypothyroid symptoms questionnaire. RESULTS: The prevalence of elevated TSH levels (normal range, 0.3-5.1 mIU/L) in this population was 9.5%, and the prevalence of decreased TSH levels was 2.2%. Forty percent of patients taking thyroid medications had abnormal TSH levels. Lipid levels increased in a graded fashion as thyroid function declined. Also, the mean total cholesterol and low-density lipoprotein cholesterol levels of subjects with TSH values between 5.1 and 10 mIU/L were significantly greater than the corresponding mean lipid levels in euthyroid subjects. Symptoms were reported more often in hypothyroid vs euthyroid individuals, but individual symptom sensitivities were low. CONCLUSIONS: The prevalence of abnormal biochemical thyroid function reported here is substantial and confirms previous reports in smaller populations. Among patients taking thyroid medication, only 60% were within the normal range of TSH. Modest elevations of TSH corresponded to changes in lipid levels that may affect cardiovascular health. Individual symptoms were not very sensitive, but patients who report multiple thyroid symptoms warrant serum thyroid testing. These results confirm that thyroid dysfunction is common, may often go undetected, and may be associated with adverse health outcomes that can be avoided by serum TSH measurement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, 25-40% of patients on long-term levothyroxine treatment have a TSH concentration below or above the reference range.7,9,10”
From Hypothyroidism (2024) · cites this paper as [10]
In the citing paper
“The prevalence of hypothyroidism (subclinical and overt) ranges from 0•2% to 5•3% in Europe 3, 35- 37 and 0•3% to 3•7% in the USA, 10 depending on the definition used and the population.”
From Hypothyroidism (2024) · cites this paper as [10]
In the citing paper
“Approximately 10-15% of patients express dissatisfaction on levothyroxine despite TSH normalisation, due to persistent, residual symptoms that might reflect ongoing hypothyroidism.10,11”
From Hypothyroidism (2024) · cites this paper as [10]
In the citing paper
“60% of unselected euthyroid individuals have one or more symptom that may be attributable to hypothyroidism. 39”
From Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association/Society for endocrinology consensus statement (2023) · cites this paper as [39]
In the citing paper
“Patientsaged 70 years or older may have fewer symptoms or signs and are less likely to exhibit someclassicsignssuchascoldintoleranceandweight gain compared with younger individuals (aged ≤ 55 years). 41”
From Hypothyroidism: A Review (2025) · cites this paper as [41]
In the citing paper
“The lack of specificity of hypothyroid symptoms and signs (49) and, particularly in case of autoimmune thyroid disease (AITD), the slow development of the pathologic state, renders difficult the assessment of the adequacy of the replacement therapy on a purely clinical basis.”
From Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014) · cites this paper as [49]
In the citing paper
“There is some evidence that patients who report more symptoms and more recently developed symptoms are more likely to have hypothyroidism.10”
From Hypothyroidism (2024) · cites this paper as [10]
In the citing paper
“symptoms consistent with the presence of hypothyroidism are nonspecific and cannot be reliably used to differentiate those with hypothyroidism from euthyroid people. 39 -41”
From Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association/Society for endocrinology consensus statement (2023) · cites this paper as [39]
In the citing paper
“Common symptoms include fatigue (74%-86%), weight gain (24%59%), cold intolerance (35%-65%), bradycardia (12%-19%), constipation(33%-41%),andcognitiveimpairment(45%-48%),includingmemorylossanddifficultyconcentrating. 41,42”
From Hypothyroidism: A Review (2025) · cites this paper as [41]
In the citing paper
“Common symptoms include fatigue (74%-86%), weight gain (24%59%), cold intolerance (35%-65%), bradycardia (12%-19%), constipation(33%-41%),andcognitiveimpairment(45%-48%),includingmemorylossanddifficultyconcentrating. 41,42”
From Hypothyroidism: A Review (2025) · cites this paper as [41]
In the citing paper
“Common symptoms include fatigue (74%-86%), weight gain (24%59%), cold intolerance (35%-65%), bradycardia (12%-19%), constipation(33%-41%),andcognitiveimpairment(45%-48%),includingmemorylossanddifficultyconcentrating. 41,42”
From Hypothyroidism: A Review (2025) · cites this paper as [41]
In the citing paper
“Common symptoms include fatigue (74%-86%), weight gain (24%59%), cold intolerance (35%-65%), bradycardia (12%-19%), constipation(33%-41%),andcognitiveimpairment(45%-48%),includingmemorylossanddifficultyconcentrating. 41,42”
From Hypothyroidism: A Review (2025) · cites this paper as [41]
In the citing paper
“Common symptoms include fatigue (74%-86%), weight gain (24%59%), cold intolerance (35%-65%), bradycardia (12%-19%), constipation(33%-41%),andcognitiveimpairment(45%-48%),includingmemorylossanddifficultyconcentrating. 41,42”
From Hypothyroidism: A Review (2025) · cites this paper as [41]
In the citing paper
“Common symptoms include fatigue (74%-86%), weight gain (24%59%), cold intolerance (35%-65%), bradycardia (12%-19%), constipation(33%-41%),andcognitiveimpairment(45%-48%),includingmemorylossanddifficultyconcentrating. 41,42”
From Hypothyroidism: A Review (2025) · cites this paper as [41]
In the citing paper
“In this respect it is noteworthy that hypothyroid symptoms were reported, despite a normal serum TSH, by 12.1% of 22,842 participants (1,525 of which were taking thyroid medication) in the Colorado Thyroid Disease Prevalence Study [17] .”
From 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism (2012) · cites this paper as [17]
In the citing paper
“Despite this, studies show that for many people levothyroxine dosage is not adjusted as they age because either monitoring for thyroid dysfunction may be not be carried out or indicated dose adjustments identified by monitoring may not be implemented.9 10 11 12 13 14”
From Levothyroxine dose and risk of fractures in older adults: nested case-control study (2011) · cites this paper as [11]
In the citing paper
“Our study specifically focused on older adults, who have a higher baseline risk of fracture15 26 56 and are more vulnerable to excessive levothyroxine replacement.11 12 13 14”
From Levothyroxine dose and risk of fractures in older adults: nested case-control study (2011) · cites this paper as [11]
In the citing paper
“Hypothyroidism is mainly induced by autoimmune thyroid diseases and thyroidectomy (1, 2).”
From Levothyroxine: conventional and novel drug delivery formulations. (2023) · cites this paper as [2]
In the citing paper
“Even though its prevalence has not been precisely documented, non-optimal thyroxine therapy, as evidenced by TSH levels above (or below) the reference range, is common (Table 2)”
From Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report (2017) · cites this paper as [13]
In the citing paper
“The prevalence of hypothyroidism increases with age and subclinical hypothyroidism affects up to 15% of adults 65 years of age or older, when non-age-specific TSH reference ranges are used (9, 12–14).”
From Levothyroxine therapy in elderly patients with hypothyroidism (2021) · cites this paper as [9]
In the citing paper
“Hypothyroid symptoms are non-specific and vary among patients, especially in the setting of subclinical hypothyroidism. The same symptoms are also quite common in euthyroid individuals and thus often overlap with the symptoms developed in patients with hypothyroidism (9).”
From Levothyroxine therapy in elderly patients with hypothyroidism (2021) · cites this paper as [9]
In the citing paper
“Five to 24 percent of all patients taking L-T4 develop iatrogenic thyrotoxicosis (9, 11, 78, 81–83), a proportion that is even higher in the elderly [up to 41% (79)].”
From Levothyroxine therapy in elderly patients with hypothyroidism (2021) · cites this paper as [9]
In the citing paper
“It is recognized that up to one-quarter of the healthy normal population may have 'hypothyroid' symptoms such as lethargy and weight gain.14”
From Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee (2016) · cites this paper as [14]
In the citing paper
“Hypothyroidism is associated with a small but significant increase in lipid parameters (31), in particular, an elevation of low-density lipoproteins (LDLs) (32).”
From Thyroid Hormones and Cardiovascular Function and Diseases (2018) · cites this paper as [31]
In the citing paper
“Overt hypothyroidism is diagnosed when serum TSH is elevated and circulating THs are low and is prevalent in 0.2% to 2% of nonpregnant adults (31,37).”
From Thyroid Hormones and Cardiovascular Function and Diseases (2018) · cites this paper as [31]
In the citing paper
“The stated prevalence of SCH in published reports ranges from 4% to 10% of the adult population, being more common in women and older individuals (31,37).”
From Thyroid Hormones and Cardiovascular Function and Diseases (2018) · cites this paper as [31]
In the citing paper
“most (at least 80%) patients with hypothyroidism have SCH (31).”
From Thyroid Hormones and Cardiovascular Function and Diseases (2018) · cites this paper as [31]
Citations
Cites
THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY
Tunbridge, W. M. G., Evered, D. C., Hall, R., Appleton, D. R., BREWIS, M., CLARK, F., Evans, J. G., Young, E. T., Bird, T., & Smith, P. (1977) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1977.tb01340.x · Cited by 2,665
Ingbar, S. H. (1965) · Archives of Internal Medicine · doi:10.1001/archinte.1965.03870060154035 · Cited by 1,745
Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons
Sawin, C. T., Geller, A., Wolf, P. A., Belanger, A. J., Baker, E., Bacharach, P., Wilson, P., Benjamin, E. J., & D'Agostino, R. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311901 · Cited by 1,259
SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MEN
Martin, M., Browner, W. S., Hulley, S. B., Kuller, L., & Wentworth, D. N. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90597-0 · Cited by 1,117
Fade, J. V., Franklyn, J. A., Cross, K. W., Jones, S. C., & Sheppard, M. C. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb01739.x · Cited by 567
Sawin, C. T. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.145.8.1386 · Cited by 439
L-Thyroxine Therapy in Subclinical Hypothyroidism: A Double-Blind, Placebo-Controlled Trial
COOPER, D. S., HALPERN, R., WOOD, L. C., LEVIN, A. A., & RIDGWAY, E. C. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-1-18 · Cited by 423
Self-citationZulewski, H., Müller, B., Exer, P., Miserez, A. R., & Staub, J.-J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3810 · Cited by 391
Applications of a New Chemiluminometric Thyrotropin Assay to Subnormal Measurement*
SPENCER, C. A., LoPRESTI, J. S., PATEL, A., GUTTLER, R. B., EIGEN, A., SHEN, D., GRAY, D., & NICOLOFF, J. T. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-2-453 · Cited by 371
Staub, J.-J., Althaus, B., Engler, H., Ryff, A., Trabucco, P., Marquardt, K., BURCKHARDT, D., Girard, J., & Weintraub, B. D. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90782-7 · Cited by 317
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,011
Saravanan, P., Simmons, D. J., Greenwood, R., Peters, T. J., & Dayan, C. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1672 · Cited by 136
Erem, C. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02464.x · Cited by 136
Thyroid disorders and polycystic ovary syndrome: An emerging relationship
Singla, R., Gupta, Y., Khemani, M., & Aggarwal, S. (2014) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.146860 · Cited by 135
Morris, M. S., Bostom, A. G., Jacques, P. F., Selhub, J., & Rosenberg, I. H. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00537-2 · Cited by 134
Neuhausen, S. L., Steele, L., Ryan, S., Mousavi, M., Pinto, M., Osann, K., Flodman, P. L., & Zone, J. J. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.06.001 · Cited by 134
McClintock, M. K., Dale, W., Laumann, E. O., & Waite, L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1514968113 · Cited by 132
Sharma, A. K., Basu, I., & Singh, S. (2017) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2017.0183 · Cited by 130
Frank‐Raue, K., Buhr, H. J., Dralle, H., Klar, E., Senninger, N. J., Weber, T., Rondot, S., Höppner, W., & Raue, F. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02216 · Cited by 130
Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2
Alkhateeb, A. M. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.6.661 · Cited by 130
Carotid intima-media thickness in patients with subclinical hypothyroidism: A meta-analysis
Gao, N., Zhang, W., Zhang, Y., Yang, Q., & Chen, S.-H. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.10.070 · Cited by 129
Bell, R. J., Rivera‐Woll, L., Davison, S. L., Topliss, D. J., Donath, S. M., & Davis, S. R. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02771.x · Cited by 129
Subclinical hypothyroidism increases the risk for depression in the elderly
Chueire, V. B., Romaldini, J. H., & Ward, L. S. (2006) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2006.02.001 · Cited by 129
Wilson, S., Parle, J., Roberts, L. M., Roalfe, A. K., Hobbs, R. F., Clark, P. M. S., Sheppard, M. C., GAMMAGE, M. D., Pattison, H. M., Franklyn, J. A., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1557 · Cited by 129
Inactivation of thyroid peroxidase by soy isoflavones, in vitro and in vivo
Doerge, D. R., & Chang, H. C. (2002) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00214-3 · Cited by 129
Environmental factors and autoimmune thyroiditis
Duntas, L. H. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0896 · Cited by 131
Thienpont, L. M., Van Uytfanghe, K., Beastall, G., Faix, J. D., Ieiri, T., Miller, W. G., Nelson, J. C., Ronin, C., Ross, H. A., Thijssen, J. H., et al. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.140178 · Cited by 128
Taylor, P. N., Medici, M. M., Hubalewska-Dydejczyk, A., & Boelaert, K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01614-3 · Cited by 128
Stanická, S., Vondra, K., Pelikánová, T., Vlček, P., Hill, M., & Zamrazil, V. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.121 · Cited by 128
Neonatal Thyroxine, Maternal Thyroid Function, and Child Cognition
Oken, E., Braverman, L. E., Platek, D., Mitchell, M. L., Lee, S. L., & Pearce, E. N. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0936 · Cited by 129
Chubb, S. A. P., Davis, W. A., & Davis, T. M. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0298 · Cited by 128
Thyroid hormone: Influences on mood and cognition in adults
RITCHIE, M. J., & Yeap, B. B. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.03.016 · Cited by 130
Screening for Endocrine Hypertension: An Endocrine Society Scientific Statement
Young, W. F., Calhoun, D. A., Lenders, J. W. M., Stowasser, M., & Textor, S. C. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00054 · Cited by 128
Celi, F. S., Zemskova, M., Linderman, J. D., Smith, S., Drinkard, B., Sachdev, V., Skarulis, M. C., Kozlosky, M., Csako, G., Costello, R., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1329 · Cited by 125
Subclinical Hypothyroidism and Cardiac Function
Biondi, B., Palmieri, E. A., Lombardi, G., & Fazio, S. (2002) · Thyroid · doi:10.1089/105072502760143890 · Cited by 125
Combination Treatment with T4 and T3: Toward Personalized Replacement Therapy in Hypothyroidism?
Biondi, B., & Wartofsky, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3399 · Cited by 124
Association between PCOS and autoimmune thyroid disease: a systematic review and meta-analysis
Romitti, M., Fabris, V. C., Ziegelmann, P. K., Maia, A. L., & Spritzer, P. M. (2018) · Endocrine Connections · doi:10.1530/ec-18-0309 · Cited by 124
Galland-Decker, C., Marques-Vidal, P. M., & Vollenweider, P. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027070 · Cited by 124
Raber, W., Gessl, A., Nowotny, P., & Vierhapper, H. (2002) · Thyroid · doi:10.1089/105072502760258712 · Cited by 124
Low Serum Vitamin D Is Associated with Anti-Thyroid Peroxidase Antibody in Autoimmune Thyroiditis
Shin, D. Y., Kim, K. J., Kim, D., Hwang, S., & Lee, E. J. (2014) · Yonsei Medical Journal · doi:10.3349/ymj.2014.55.2.476 · Cited by 122
The mechanisms of atrial fibrillation in hyperthyroidism
Bielecka-Dabrowa, A., Mikhailidis, D. P., Rysz, J., & Banach, M. (2009) · Thyroid Research · doi:10.1186/1756-6614-2-4 · Cited by 121
Völzke, H., Schwahn, C., Wallaschofski, H., & Dörr, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0179 · Cited by 120
Rong, F., Dai, H., Wu, Y., Li, J., Liu, G., Chen, H., & Zhang, X. (2021) · BMC Medicine · doi:10.1186/s12916-021-02121-2 · Cited by 127
Rayman, M. P., Thompson, A. J., Bekaert, B., Catterick, J., Galassini, R., Hall, E., Warren-Perry, M., & Beckett, G. J. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.2.370 · Cited by 120
Hamilton, T. E., Davis, S., Onstad, L., & Kopecky, K. J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2300 · Cited by 120
Gender differences in thyroid system function: relevance to bipolar disorder and its treatment
Bauer, M., Glenn, T., Pilhatsch, M., Pfennig, A., & Whybrow, P. C. (2013) · Bipolar Disorders · doi:10.1111/bdi.12150 · Cited by 125
Thyroid Dysfunction and Women's Reproductive Health
Redmond, G. P. (2004) · Thyroid · doi:10.1089/105072504323024543 · Cited by 121
Vadiveloo, T., Donnan, P. T., Cochrane, L., & Leese, G. P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0854 · Cited by 118
Changes in the prevalence of hypothyroidism: the HUNT Study in Norway
Åsvold, B. O., Vatten, L. J., & Bjøro, T. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0459 · Cited by 118
The history and future of treatment of hypothyroidism
McAninch, E. A., & Bianco, A. C. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1799 · Cited by 118
Subclinical hypothyroidism in childhood — current knowledge and open issues
Salerno, M., Capalbo, D., Cerbone, M., & Luca, F. D. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.100 · Cited by 118
Tissue-Specific Effects of Loss of Estrogen during Menopause and Aging
Wend, K., Wend, P., & Krum, S. A. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00019 · Cited by 122
Camargo, R. Y. A., Tomimori, E. K., Neves, S. C., Rubio, I. G. S., Galrão, A. L., Knobel, M., & Medeiros-Neto, G. A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0192 · Cited by 116
The cost-effectiveness of universal screening in pregnancy for subclinical hypothyroidism
Thung, S. F., Funai, E. F., & Grobman, W. A. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.10.035 · Cited by 115
Hypothyroidism and Thyroiditis
Brent, G. A., & Davies, T. F. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00013-4 · Cited by 115
Association Between Thyroid Dysfunction and Total Cholesterol Level in an Older Biracial Population
Kanaya, A. M., Harris, F., Volpato, S., Pérez‐Stable, E. J., Harris, T. B., & Bauer, D. C. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.7.773 · Cited by 115
KASAGI, K., Takahashi, N., Inoue, G., Honda, T., Kawachi, Y., & Izumi, Y. (2009) · Thyroid · doi:10.1089/thy.2009.0205 · Cited by 115
Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report
Centanni, M., Benvenga, S., & Sachmechi, I. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0706-y · Cited by 113
Prevalence of undiagnosed hypothyroidism in Europe: a systematic review and meta-analysis.
Mendes, D., Alves, C., Silverio, N., & Batel Marques, F. (2019) · European Thyroid Journal · doi:10.1159/000499751 · Cited by 113
Secondary Causes of Osteoporosis
Hudec, S. M. D., & Camacho, P. M. (2012) · Endocrine Practice · doi:10.4158/ep12059.ra · Cited by 115
Hypothyroidism in the older population
Leng, O., & Razvi, S. (2019) · Thyroid Research · doi:10.1186/s13044-019-0063-3 · Cited by 112
Cognitive and affective status in mild hypothyroidism and interactions with l-thyroxine treatment
Bono, G., Fancellu, R., Blandini, F., Santoro, G., & Mauri, M. F. (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00262.x · Cited by 112
Alteration of Lipid Profile in Subclinical Hypothyroidism: A Meta-Analysis
Xu, J. (2014) · Medical Science Monitor · doi:10.12659/msm.891163 · Cited by 111
Kim, W. G., Kim, W. B., Woo, G.-J., Kim, H.-J., Cho, Y., Kim, T. Y., Kim, S. W., Shin, M., Park, J. W., Park, H., et al. (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.1.106 · Cited by 110
Thyroid hormone therapy for hypothyroidism
Biondi, B., & Cooper, D. S. (2019) · Endocrine · doi:10.1007/s12020-019-02023-7 · Cited by 112
Park, Y. J., Lee, E., Lee, Y. J., Choi, S. H., Park, J. H., Lee, S. B., Lim, S. K., Lee, W., Jang, H. C., Cho, B. Y., et al. (2009) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2009.05.015 · Cited by 110
Thyroid Hormone Metabolism in Patients with Congestive Heart Failure: The Low Triiodothyronine State
Ascheim, D. D., & Hryniewicz, K. M. (2002) · Thyroid · doi:10.1089/105072502760143908 · Cited by 110
Second-Trimester Reference Intervals for Thyroid Tests: The Role of Ethnicity
La’ulu, S. L., & Roberts, W. L. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.089680 · Cited by 111
Prevalence and Risk Factors of Subclinical Thyroid Disease
Kim, Y. A., & Park, Y. J. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.1.20 · Cited by 109
Thyroid Function and Cognition during Aging
Bégin, M. E., Langlois, M., Lorrain, D., & Cunnane, S. C. (2008) · Current Gerontology and Geriatrics Research · doi:10.1155/2008/474868 · Cited by 109
Takashima, N., Niwa, Y., Mannami, T., Tomoike, H., & Iwai, N. (2007) · Circulation Journal · doi:10.1253/circj.71.191 · Cited by 108
Subclinical hypothyroidism: a historical view and shifting prevalence
Hennessey, J. V., & Espaillat, R. (2015) · International Journal of Clinical Practice · doi:10.1111/ijcp.12619 · Cited by 111
Thyroid autoimmunity in Type 1 diabetes: systematic review and meta‐analysis
Shun, C.-H., Donaghue, K. C., Phelan, H., Twigg, S. M., & Craig, M. E. (2013) · Diabetic Medicine · doi:10.1111/dme.12318 · Cited by 107
Benetti‐Pinto, C. L., Piccolo, V. B., Garmes, H. M., & Juliato, C. R. T. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.10.006 · Cited by 107
Risk factors for radiation‐induced hypothyroidism
Vogelius, I. R., Bentzen, S. M., Maraldo, M. V., Petersen, R. H., & Specht, L. (2011) · Cancer · doi:10.1002/cncr.26186 · Cited by 106
Cardiovascular Effects of Mild Hypothyroidism
Biondi, B. (2007) · Thyroid · doi:10.1089/thy.2007.0158 · Cited by 106
Higgins, K. M., Mandell, D. L., Govindaraj, S., Genden, E. M., Mechanick, J. I., Bergman, D. A., Diamond, E. J., & Urken, M. L. (2004) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.130.1.63 · Cited by 105
DIAGNOSIS OF ENDOCRINE DISEASE: How reliable are free thyroid and total T3 hormone assays?
Welsh, K. J., & Soldin, S. J. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0193 · Cited by 124
Silveira, M. G., Mendes, F. D., Diehl, N. N., Enders, F., & Lindor, K. D. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02003.x · Cited by 103
PBDE flame retardants, thyroid disease, and menopausal status in U.S. women
Allen, J. G., Gale, S. L., Zoeller, R. T., Spengler, J. D., Birnbaum, L. S., & McNeely, E. (2016) · Environmental Health · doi:10.1186/s12940-016-0141-0 · Cited by 107
MECHANISMS IN ENDOCRINOLOGY: Aging and anti-aging: a Combo-Endocrinology overview
Diamanti‐Kandarakis, E., Dattilo, M., Μacut, D., Duntas, L. H., Gonos, E. S., Goulis, D. G., Kanaka‐Gantenbein, C., Καπετάνου, Μ., Koukkou, E. G., Lambrinoudaki, I. V., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-1061 · Cited by 105
Rapa, A., Monzani, A., Moia, S., Vivenza, D., Bellone, S., Petri, A., Teofoli, F., Cassio, A., Cesaretti, G., Corrias, A., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0375 · Cited by 106
Teixeira, P. D. F. D. S., Reuters, V. S., Ferreira, M. M., Almeida, C. D. P., Reis, F. A. A., Buescu, A., Costa, A. J. L., & Vaisman, M. (2008) · Translational research · doi:10.1016/j.trsl.2007.12.006 · Cited by 104
Health Status, Mood, and Cognition in Experimentally Induced Subclinical Hypothyroidism
Samuels, M. H., Schuff, K. G., Carlson, N. E., Carello, P., & Janowsky, J. S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0011 · Cited by 102
MECHANISMS IN ENDOCRINOLOGY: Thyroid and polycystic ovary syndrome
Gaberšček, S., Zaletel, K., Theiler‐Schwetz, V., Pieber, T. R., Obermayer-Pietsch, B. M., & Lerchbaum, E. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0295 · Cited by 103
Rhee, C. M., Brent, G. A., Kovesdy, C. P., Soldin, O. P., Nguyen, D. V., Budoff, M. J., Brunelli, S. M., & Kalantar‐Zadeh, K. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu024 · Cited by 103
Monzani, A., Prodam, F., Rapa, A., Moia, S., Agarla, V., Bellone, S., & Bona, G. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0656 · Cited by 101
Goichot, B., Caron, P., Landron, F., & Bouée, S. (2015) · Clinical Endocrinology · doi:10.1111/cen.12816 · Cited by 101
The clinical content of preconception care: women with chronic medical conditions
Dunlop, A. L., Jack, B. W., Bottalico, J. N., Lu, M., James, A., Shellhaas, C., Hallstrom, L. H.-K., Solomon, B. D., Feero, W. G., Menard, M. K., et al. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.08.031 · Cited by 102
Thyroid Disease and Vascular Function
Owen, P. J. D., Sabit, R., & Lazarus, J. H. (2007) · Thyroid · doi:10.1089/thy.2007.0051 · Cited by 101
Lee, Y. K., Kim, J. E., Oh, H. J., Park, K. S., Kim, S. K., Park, S. W., Kim, M. J., & Cho, Y. W. (2011) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2011.26.4.432 · Cited by 100
Levothyroxine overuse: time for an about face?
Rodriguez-Gutierrez, R., Maraka, S., Ospina, N. S., Montori, V. M., & Brito, J. P. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30276-5 · Cited by 100
Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers
Jonklaas, J., & Razvi, S. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30371-1 · Cited by 100
Kurtkulağı, Ö., Tel, B. M. A., Kahveci, G. B., Bilgin, S., Duman, T. T., Ertürk, A., Balci, B., & Aktaş, G. (2021) · Romanian Journal of Internal Medicine · doi:10.2478/rjim-2021-0023 · Cited by 100
WHEN TO TREAT MILD HYPOTHYROIDISM
Ayala, A. R., Danese, M. D., & Ladenson, P. W. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70139-0 · Cited by 101
Yazici, M., Gorgulu, S., Sertbas, Y., Erbilen, E., Albayrak, S., Yildiz, O., & Uyan, C. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.05.015 · Cited by 99
Cerbone, M., Bravaccio, C., Capalbo, D., Polizzi, M., Wasniewska, M. G., Cioffi, D., Improda, N., Valenzise, M., Bruzzese, D., Luca, F. D., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0979 · Cited by 99
Natural history, diagnosis and management of subclinical thyroid dysfunction
Biondi, B. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.12.004 · Cited by 98
Peeters, R. P. (2008) · Hormones · doi:10.14310/horm.2002.1111035 · Cited by 98
Villagelin, D., Romaldini, J. H., dos Santos, R. B., Milkos, A. B. B. P., & Ward, L. S. (2015) · Thyroid · doi:10.1089/thy.2015.0195 · Cited by 100
Are lower TSH cutoffs in neonatal screening for congenital hypothyroidism warranted?
Lain, S. J., Trumpff, C., Grosse, S. D., Olivieri, A., & Vliet, G. V. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0107 · Cited by 98
Sun, J., Yao, L., Fang, Y., Yang, R., Chen, Y., Yang, K., & Tian, L. (2017) · International Journal of Endocrinology · doi:10.1155/2017/8130796 · Cited by 101
Neuropsychiatric Manifestations of Thyroid Disease
Feldman, A. Z., Shrestha, R. T., & Hennessey, J. V. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.05.005 · Cited by 98
The Relation of Thyroid Function to Components of the Metabolic Syndrome in Korean Men and Women
Park, S. B., Choi, H.-C., & Joo, N. S. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.4.540 · Cited by 98
Wouters, H. J. C. M., van Loon, H. C. M., van der Klauw, M. M., Elderson, M. F., Slagter, S. N., Kobold, A. M., Kema, I. P., Links, T. P., van Vliet-Ostaptchouk, J. V., & Wolffenbuttel, B. H. R. (2017) · Thyroid® · doi:10.1089/thy.2016.0199 · Cited by 97
Adequacy of thyroid hormone replacement in a general population
Okosieme, O. E., Belludi, G., Spittle, K., Kadiyala, R., & Richards, J. (2011) · QJM · doi:10.1093/qjmed/hcq222 · Cited by 96
Managing thyroid disease in general practice
Walsh, J. P. (2016) · The Medical Journal of Australia · doi:10.5694/mja16.00545 · Cited by 96
Carlé, A., Pedersen, I. B., Knudsen, N., Perrild, H., Ovesen, L., & Laurberg, P. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0481 · Cited by 95
High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome
Garelli, S., Masiero, S., Plebani, M., Chen, S., Furmaniak, J., Armanini, D., & Betterle, C. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.03.003 · Cited by 95
Toxicology Review and Risk Assessment of Resorcinol: Thyroid Effects
Lynch, B. S., Delzell, E., & Bechtel, D. H. (2002) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2002.1585 · Cited by 95
Ge, J., Xu, Y., Qin, G., Cheng, J., & Chen, F. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00044 · Cited by 95
Metadata
- Authors
- Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C.
- Affiliations
- University of Nebraska Medical Center (US)
- Abbott (United States) (US)
- University of Colorado Denver (US)
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2000-02-28
- Volume
- 160
- Issue
- 4
- Pages
- 526
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2140936682
- Cited by
- 2,824
- References
- 50
- Citations by year
- 2026: 49 · 2025: 64 · 2024: 86 · 2023: 138 · 2022: 158 · 2021: 151 · 2020: 191 · 2019: 147 · 2018: 148 · 2017: 166 · 2016: 161 · 2015: 140 · 2014: 144 · 2013: 147 · 2012: 132
- FWCI
- 31.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- thyroid dysfunction, hypothyroidism, thyroid-stimulating hormone, thyroxine, serum lipids, cholesterol, LDL cholesterol, thyroid medication, cardiovascular risk
- MeSH terms
- Adult, Age Factors, Aged, Colorado, Cross-Sectional Studies, Diagnosis, Differential, Female, Humans, Lipids, Male, Middle Aged, Surveys and Questionnaires, Sex Factors, Thyroid Diseases, Thyroid Hormones, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
